Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +84.1% | +200.6% | 3 / 3 | +42.0% | -3.12 pp | +0.42 pp | +11.3% | 0.57 | 3.58 | 457 | +42,0% | 7,9 | +87,6% | 3.58 | 5.64 | −36,5% |
| Pts | 12 | 12 | 12 | 12 | 0 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 4.100 (close price on 2026-10-19)EPS (TTM): 1.144
Financial charts
1.Revenue & growth
VND bn457Q2/26
1.Revenue & growth
VND bn457Q2/26
2.Profit & growth
VND bn7,57Q2/26
3.Profit mix (Penman)
VND bn60,8Q2/26
4.Margins & cost structure
%-0.5%Q2/26
5.Returns & cash cycle
% · days-5.0%Q2/26
6.Earnings quality & cash
VND bn-3,10Q2/26
7.Asset structure
VND bn1.018Q2/26
8.Funding & debt health
VND bn · times1.018Q2/26
9.Revenue backlog
VND bn2,86Q2/26
10.Valuation
times · %3,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %144Q2/26
Adjusted EPS growth, latest quarter
84.1%
Average adjusted EPS growth, 3 quarters
84.1%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26